![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
概括
毛囊淋巴瘤治疗面临挑战,原因是患者的结果和副作用变化. 未来的战略重点是个性化,适应风险的疗法和新型药物,以改善生存和生活质量.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床治疗学 临床治疗学
背景情况:
- 毛囊性淋巴瘤 (FL) 是最常见的惰性淋巴瘤.
- 目前的第一线疗法,包括抗CD20抗体和维持策略,可以改善无进展生存率,但缺乏标准化的方法.
- 在FL的高预后变化使治疗决策复杂化,现有的得分无法可靠地识别高风险患者.
研究的目的:
- 审查目前和未来的战略,以优化卵泡淋巴瘤的第一线治疗.
- 解决改善预后和预测工具的需求.
- 探索减少不良事件和提高患者生活质量的方法.
主要方法:
- 审查最近的临床试验和治疗进步在毛囊淋巴瘤.
- 对现有的预后分数及其局限性的分析.
- 讨论新兴的预测工具和新的治疗方法.
主要成果:
- 尽管有进展,但由于传染性不良事件和缺乏整体生存益处,没有任何一项一线策略被普遍采用.
- 现有的预后模型不足以在临床实践中准确地分层风险.
- 对于识别和治疗约20%的高风险患者,仍然存在重大未满足的需求.
结论:
- 重塑前线治疗模式对于改善卵泡淋巴瘤结果至关重要.
- 未来的战略涉及风险或响应适应的设计和新的预测工具.
- 减少不良事件和探索T细胞参与治疗可能会提高生存率和生活质量.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K